enVVeno Medical Corporation (NVNO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.24M | -3.44M | -4.39M | -3.71M | -4.02M | -5.11M | -4.28M | -3.91M | -3.55M | -4.97M | -4.21M | -4.56M | -5.11M | -3.86M | -4.48M | -3.96M | -3.32M | -3.1M | -2.23M | -2.67M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 19.41% | 32.56% | -2.71% | 4.94% | -13.21% | -2.65% | -1.5% | 14.35% | 30.53% | -28.97% | 6.02% | -15.26% | -53.84% | -24.41% | -100.69% | -48.22% | 13.55% | -18.58% | 13.81% | -102.39% |
| Net Income | -3.85M | -3.74M | -2.41M | -8.82M | -4.5M | -6.23M | -5.64M | -4.96M | -4.99M | -5.65M | -5M | -6.47M | -6.39M | -6.18M | -6.1M | -7.06M | -5.33M | -8.99M | -2.39M | -2.38M |
| Depreciation & Amortization | 124K | 117K | 105.5K | 144.5K | 122K | 122K | 129K | 136K | 141K | 134K | 138K | 138K | 136K | 130K | 133K | 133K | 129K | 121.59K | 120.14K | 107.5K |
| Stock-Based Compensation | 0 | 637K | 239.12K | 1.89M | 651K | 1.02M | 1M | 1M | 1.11M | 1.14M | 1.1M | 1.16M | 1.79M | 2.24M | 2.21M | 2.24M | 2.24M | 5.34M | 325K | 202.12K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.14M | 2.05M | -7.2M | 0 | 0 | 0 | 0 | 0 | 0 | -312.7K | 0 |
| Other Non-Cash Items | 514K | 79K | -1.62M | 1.74M | 194K | 118K | -3K | -47K | -43K | -5.04M | -2.21M | 7.06M | -277K | -256K | -2K | 103K | -47K | -76.96K | -78.55K | -78.55K |
| Working Capital Changes | -27K | -540K | -700K | 1.33M | -482K | -134K | 240K | -46K | 230K | -701K | -297K | 750K | -368K | 212K | -727K | 629K | -316K | 500.82K | 101.63K | -524.2K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 15K | -382K | -524K | 1.35M | -440K | -141K | 568K | 161K | 110K | -705K | -172K | 924K | -268K | 147K | -533K | 477K | -3K | 165.89K | 85.31K | -402.78K |
| Cash from Investing | 2.77M | 4.18M | 3.65M | 2.82M | 5.2M | -11.06M | 6.22M | 3.97M | 2.2M | -22.14M | 4.45M | 7M | 2.83M | 5.52M | -1.69M | -38.31M | -69K | -64.75K | -152.63K | -126.48K |
| Capital Expenditures | 0 | 0 | -126.48K | 121.48K | 0 | -4K | -9K | -14K | -10K | -4K | -3K | -21K | -5K | -9K | -14K | -23K | -69K | -64.75K | -152.63K | -126.48K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.3K | -4.45K | -7.03K | -2.83K | -5.53K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 5.33M | -5.33M | 0 | 0 | 0 | 0 | 0 | -14.3K | 4.45K | 7.03K | 2.83K | 5.53K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 782K | 241K | 0 | 0 | 0 | 13.59M | 0 | 46K | 25.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.05K | 19.24M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 782K | 241K | 0 | 0 | 0 | 13.59M | 0 | 46K | 25.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K | 970.58K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50 | 18.27M | 0 |
| Net Change in Cash | -468K | 1.52M | -500K | -893K | 1.18M | -16.16M | 15.54M | 66K | -1.31M | -1.33M | 232K | 2.44M | -2.28M | 1.66M | -6.17M | -42.27M | -3.39M | -3.17M | 16.86M | -2.8M |
| Free Cash Flow | -3.24M | -3.44M | -4.39M | -3.72M | -4.02M | -5.11M | -4.29M | -3.92M | -3.56M | -4.98M | -4.22M | -4.58M | -5.11M | -3.87M | -4.5M | -3.98M | -3.39M | -3.16M | -2.39M | -2.8M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 19.41% | 32.61% | -2.5% | 5.15% | -12.9% | -2.65% | -1.64% | 14.44% | 30.41% | -28.77% | 6.25% | -15.12% | -50.86% | -22.15% | -88.44% | -42.34% | 12.31% | -19.8% | 8.8% | -93.97% |
| FCF per Share | -4.95 | -5.85 | -266.94 | -223.91 | -241.84 | -307.11 | -326.70 | -299.02 | -271.51 | -457.82 | -459.86 | -500.00 | -557.81 | -499.87 | -490.56 | -434.38 | -369.80 | -346.07 | -318.44 | -402.58 |
| FCF Conversion (FCF/Net Income) | 0.84x | 0.92x | 0.97x | 0.55x | 0.89x | 0.82x | 0.76x | 0.79x | 0.71x | 0.88x | 0.84x | 0.70x | 0.80x | 0.62x | 0.74x | 0.56x | 0.62x | 0.34x | 0.93x | 1.12x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |